Product Details for: GENGLYCOS
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Suspension
Intravenous
3x10^13VG/ML
Single-Dose Vial
351(a)
GENGLYCOS
Rx
Proper Name
pariglasgene brecaparvovec-opnr
pariglasgene brecaparvovec-opnr
BLA Number
125858
125858
Applicant
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc.
Original Approval Date
August 19, 2026
August 19, 2026
Date of First Licensure